跳至主要内容
临床试验/CTRI/2020/04/024851
CTRI/2020/04/024851尚未招募3 期

Randomised controlled trial to test the efficacy of herbal mouth wash in managing acute toxicity of radiation in Head & Neck cancer patients

Regional Cancer Centre Trivandrum1 个研究点 分布在 1 个国家目标入组 129 人开始时间: 2020年4月30日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
129
试验地点
1
主要终点
To find out whether the two forms of mouth wash is useful in minimizing side effects of radiation in patients undergoing radiotherapy for oral cancers in terms of oral hygiene, in minimising oral mucositis and in decreasing the severity of analgesic and antibiotic usage.

研究概览

简要总结

Randomised controlled trial totest the efficacy of herbal mouth wash in managing acute toxicity of radiationin Head & Neck cancer patients

Introduction

Oral mucositis is the major dose limiting side effect for patients withoral cancer undergoing radiotherapy. Mucositis  can interfere with thepatient’s ability to maintain adequate intake of food and liquids.  Severe mucositis can lead to treatmentinterruptions or premature termination of therapy resulting in poor tumourcontrol and survival.  All patientsundergoing radiotherapy to oral cavity develop some degree of mucositis

Several agentshave been tried to minimize the severity of oral mucositis.  But so far, no method has mentioned has beenfound to be effective. Regional Cancer Centre, Trivandrum has done a studyearlier using an ayurvedic mouth wash containing 5 plant ingredients-Emblicaofficinalis (dried fruit), Terminalia chebula (dried fruit), Terminalia bellerica(dried fruit), Azadiracta indica (leaf & Bark), Glycyrrhiza glabra (root) inpatients undergoing radiotherapy for oral cancer1. One hundred andforty eight patients were randomly assigned to use ayurvedic mouth wash or thestandard practice of soda / saline mouthwash.

 The ayurvedicmouth wash delayed the onset of oral mucositis during radiotherapy. Oralhygiene was significantly better in patients using ayurvedic mouth wash. Analgesic  and antibiotic requirements were also low inthese patients.  There was a significantdecrease in the late side effects of radiation to the oral cavity such as drynessof mouth, intolerance to spicy food in the patients who used ayurvedic  mouthwash. Use of this mouth wash did notaffect the response to radiotherapy in  these patients.

The majordrawback of this mouth wash was the process of preparation of the mouth wash bythe patient and also the shelf life.  Inorder to overcome this RCC in collaboration with RGCB and Ceego Labs Pvt Ltd,Chennai has developed mouth wash using the same ingredients with the samequantity in two forms; one as a ready to use liquid form and another one in apowder form which can be dissolved in water and can be used.

 Aim

To find outwhether these two forms of mouth wash is useful in minimizing the side effectsof radiation in patients undergoing radiotherapy for Head & Neck Cancers

Methodology

Patientswith oral cancer undergoing radical / adjuvant radiotherapy with or withoutsurgery will be randomized into 3 arms after getting informed consent.  Those who require adjuvant chemoradiationwill not be included.  However, inductionchemotherapy is not an exclusion criteria. One arm will be using the liquid form of mouthwash 5 ml dissolved in 20ml of water.  Second one will be usingmouth wash prepared by dissolving 30 gm of the powder dissolved in 300 ml ofwater and the control arm will be using the soda saline mouthwash.  All patients will be advised to rinse themouth with the mouth wash 4 times daily during the entire course ofradiotherapy treatment.

 All these patients will be evaluatedweekly. Mucositis grade will be expressed on a 5-point scale using RTOG / ECOGscoring system.  The intensity of pain,dryness of mouth, alteration and taste will be scored on a 10 – point scaleusing a Visual Analogus Scale (VAS).  The use of analgesics, antibiotics and antifungal and oral hygiene willbe recorded in a structured proforma.   Measurements of Weight (Wt) will be done before and afterradiotherapy.  All these patients will bereviewed 6 weeks following the treatment to evaluate the degree of xerostomia,intolerance to spicy food and the tumour response.

 The sample sizeis calculated based on the previous study. Assuming 80% power, 5% and error sample size required is 43 in each arm

 Reference

1.    R Kunnambath, D Ravindran, R RKumar, R.Muwonge, R.M. Pillai. Management of Radiation-Induced Oral MucositisWith a Herbal Mouthwash. Int J Radiat Oncol Biol Phys.2013; 87(Supplement 2): S143.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patients with oral cancer undergoing radical / adjuvant radiotherapy with or without surgery will be included.

排除标准

  • Patients who require adjuvant chemoradiation will not be included.

结局指标

主要结局

To find out whether the two forms of mouth wash is useful in minimizing side effects of radiation in patients undergoing radiotherapy for oral cancers in terms of oral hygiene, in minimising oral mucositis and in decreasing the severity of analgesic and antibiotic usage.

时间窗: At baseline, Weekly, | at the end of radiotherapy treatment and 6 weeks after the treatment

次要结局

  • degree of xerostomia, intolerance to spicy food and the tumour response.(6 weeks after the completion of treatment)

研究者

发起方
Regional Cancer Centre Trivandrum
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验